BIODESIX, INC. Earnings Per Share (Basic)
BIODESIX, INC. (BDSX) reported Earnings Per Share (Basic) of -$0.71 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- BIODESIX, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.71.
- BIODESIX, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.81.
- BIODESIX, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.49.
- BIODESIX, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.16.
- BIODESIX, INC. earnings per share, basic for fiscal 2025 was -$4.67.
- BIODESIX, INC. earnings per share, basic for fiscal 2024 was -$6.64.
- BIODESIX, INC. earnings per share, basic for fiscal 2023 was -$0.64.
- BIODESIX, INC. earnings per share, basic for fiscal 2022 was -$1.55.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.71 10-Q · filed 2026-08-05 | -$1.51 10-Q · filed 2026-08-05 | -$2.04 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$3.13 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2026-03-31 | -$0.81 10-Q · filed 2026-05-04 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.44 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$3.93 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$3.17 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$4.67 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$1.16 10-Q · filed 2025-11-03 | -$2.72 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$4.24 10-Q · filed 2025-11-03 | -$5.37 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-06-30 | -$1.56 10-Q · filed 2026-08-05 | -$0.08 10-Q · filed 2025-08-07 | -$3.08 10-Q · filed 2026-08-05 | -$0.15 10-Q · filed 2025-08-07 | -$4.21 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$5.61 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||
| 2025-03-31 | -$1.52 10-Q · filed 2026-05-04 | -$0.08 10-Q · filed 2025-05-13 | -$2.64 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$4.05 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-05 | |||
| 2024-12-31 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$2.53 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$6.64 10-K · filed 2026-02-26 | -$0.33 10-K · filed 2025-03-03 | |||
| 2024-09-30 | -$1.40 10-Q · filed 2025-11-03 | -$0.07 10-Q · filed 2024-11-01 | -$0.31 derived: net income ÷ weighted average shares · filed 2025-11-03 | -$5.61 10-Q · filed 2025-11-03 | -$0.28 10-Q · filed 2024-11-01 | -$0.54 derived: net income ÷ weighted average shares · filed 2025-11-03 | ||
| 2024-06-30 | -$0.08 10-Q · filed 2025-08-07 | -$0.22 10-Q · filed 2025-08-07 | -$0.32 derived: net income ÷ weighted average shares · filed 2025-11-03 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-11-03 | ||||
| 2024-03-31 | -$0.14 10-Q · filed 2025-05-13 | -$0.24 derived: net income ÷ weighted average shares · filed 2025-11-03 | -$0.38 derived: net income ÷ weighted average shares · filed 2025-11-03 | -$0.54 derived: net income ÷ weighted average shares · filed 2025-11-03 | ||||
| 2023-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$0.23 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$0.40 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$0.64 10-K · filed 2025-03-03 | ||||
| 2023-09-30 | -$0.14 10-Q · filed 2024-11-01 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-01 | -$0.55 10-Q · filed 2024-11-01 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-11-01 | ||||
| 2023-06-30 | -$0.17 10-Q · filed 2024-08-07 | -$0.41 10-Q · filed 2024-08-07 | -$0.74 derived: net income ÷ weighted average shares · filed 2024-11-01 | -$1.04 derived: net income ÷ weighted average shares · filed 2024-11-01 | ||||
| 2023-03-31 | -$0.24 10-Q · filed 2024-05-08 | -$0.58 derived: net income ÷ weighted average shares · filed 2024-11-01 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-11-01 | -$1.28 derived: net income ÷ weighted average shares · filed 2024-11-01 | ||||
| 2022-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2024-03-01 | -$0.69 derived: net income ÷ weighted average shares · filed 2024-03-01 | -$1.09 derived: net income ÷ weighted average shares · filed 2024-03-01 | -$1.55 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | -$0.34 10-Q · filed 2023-11-07 | -$0.74 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.22 10-Q · filed 2023-11-07 | -$1.69 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-06-30 | -$0.40 10-Q · filed 2023-08-07 | -$0.89 10-Q · filed 2023-08-07 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.79 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-03-31 | -$0.50 10-Q · filed 2023-05-11 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.41 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$2.34 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2021-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.88 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.58 10-K · filed 2023-03-06 | ||||
| 2021-09-30 | -$0.41 10-Q · filed 2022-11-03 | -$1.50 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.09 10-Q · filed 2022-11-03 | |||||
| 2021-06-30 | -$4.52 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$7.29 derived: net income ÷ weighted average shares · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |